Skip to main content
SpringerLink
Log in

Other Skin Cancers

Fibrohistiocytic Skin Cancers and Extramammary Paget's Disease

  • Chapter
Managing Skin Cancer

  • 955 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gloster HM Jr (1996) Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35(3 Pt 1):355–374; quiz 375–6

    Article  PubMed  Google Scholar 

  2. Ah-Weng A et al (2002) Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer 87(12):1386–1389

    Article  PubMed  CAS  Google Scholar 

  3. Young CR III, Albertini MJ (2003) Atrophic dermatofibrosar-coma protuberans: case report, review, and proposed molecular mechanisms. J Am Acad Dermatol 49(4):761–764

    Article  PubMed  Google Scholar 

  4. Davis DA, Sanchez RL (1998) Atrophic and plaquelike der-matofibrosarcoma protuberans. Am J Dermatopathol 20(5):498–501

    Article  PubMed  CAS  Google Scholar 

  5. Nouri K et al (2002) Mohs micrographic surgery for dermatofi-brosarcoma protuberans: University of Miami and NYU experience. Dermatol Surg 28(11):1060–1064; discussion 1064

    Article  PubMed  Google Scholar 

  6. Haycox CL et al (1997) Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modeling and a review of cases treated with Mohs micrographic surgery. Ann Plast Surg 38(3):246–251

    Article  PubMed  CAS  Google Scholar 

  7. Kimmel Z et al (2007) Peripheral excision margins for der-matofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol 14(7):2113–2120

    Article  PubMed  Google Scholar 

  8. Ratner D et al (1997) Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 37(4):600–613

    Article  CAS  Google Scholar 

  9. Parker TL, Zitelli JA (1995) Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol 32(2 Pt 1):233–236

    Article  PubMed  CAS  Google Scholar 

  10. Haycox CL et al (1997) Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol 37(3 Pt 1):438–444

    Article  PubMed  CAS  Google Scholar 

  11. Jimenez FJ et al (1994) Immunohistochemical margin control applied to Mohs micrographic surgical excision of der-matofibrosarcoma protuberans. J Dermatol Surg Oncol 20(10):687–689

    PubMed  CAS  Google Scholar 

  12. Breuninger H, Schaumburg-Lever G (1988) Control of exci-sional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Mohs' technique. J Pathol 154(2):167–171

    Article  PubMed  CAS  Google Scholar 

  13. Breuninger H, Thaller A, Schippert W (1994) [Subclinical spread of dermatofibrosarcoma protuberans and resulting treatment modalities]. Hautarzt 45(8):541–545

    Article  PubMed  CAS  Google Scholar 

  14. McArthur GA (2007) Molecular targeting of dermatofibro-sarcoma protuberans: a new approach to a surgical disease. J Natl Compr Canc Netw 5(5):557–562

    PubMed  Google Scholar 

  15. Wright TI, Petersen JE (2007) Treatment of recurrent der-matofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery. Dermatol Surg 33(6):741–744

    Article  PubMed  CAS  Google Scholar 

  16. Stadler FJ, Scott GA, Brown MD (1998) Malignant fibrous tumors. Semin Cutan Med Surg 17(2):141–152

    Article  PubMed  CAS  Google Scholar 

  17. Giuffrida TJ, Kligora CJ, Goldstein GD (2004) Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 30(12 Pt 2):1561–1564

    Article  PubMed  CAS  Google Scholar 

  18. Seavolt M, McCall M (2006) Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with mohs micrographic surgery. Dermatol Surg 32(3):435–441; discussion 439–41

    Article  PubMed  CAS  Google Scholar 

  19. Sakamoto A et al (2001) H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 32(11):1225–1231

    Article  PubMed  CAS  Google Scholar 

  20. DeiTos AP et al (1994) Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 145(1):11–17

    CAS  Google Scholar 

  21. Tos AP (2006) Classification of pleomorphic sarcomas: where are we now? Histopathology 48(1):51–62

    Article  Google Scholar 

  22. Hultgren TL, DiMaio DJ (2007) Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 34(5):415–419

    Article  PubMed  Google Scholar 

  23. Davis JL et al (1997) A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 23(2):105–110

    Article  PubMed  Google Scholar 

  24. Helwig EB, May D (1986) Atypical fibroxanthoma of the skin with metastasis. Cancer 57(2):368–376

    Article  PubMed  CAS  Google Scholar 

  25. Jacobs DS, Edwards WD, Ye RC (1975) Metastatic atypical fibroxanthoma of skin. Cancer 35(2):457–463

    Article  PubMed  CAS  Google Scholar 

  26. Limmer BL, Clark DP (1997) Cutaneous micrographic surgery for atypical fibroxanthoma. Dermatol Surg 23(7):553–557; discussion 557–8

    Article  PubMed  CAS  Google Scholar 

  27. Huether MJ, Zitelli JA, Brodland DG (2001) Mohs micro-graphic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 44(4):656–659

    Article  PubMed  CAS  Google Scholar 

  28. Nouri K, Rivas MP (2004) A primer of Mohs micrographic surgery: uncommon indications. Skinmed 3(5):259–265

    Article  PubMed  Google Scholar 

  29. Fletcher CDM, Unni KK, Mertens F (2002) Pathology and genetics of tumors of soft tissue and bone. WHO classification of tumours. ARC Press, Lyon

    Google Scholar 

  30. Fletcher CD (1992) Pleomorphic malignant fibrous histiocy-toma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16(3):213–228

    Article  PubMed  CAS  Google Scholar 

  31. Mentzel T et al (1996) Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 20(4):391–405

    CAS  Google Scholar 

  32. Fletcher CD et al (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19(12):3045–3050

    PubMed  CAS  Google Scholar 

  33. Coindre JM et al (2004) Inflammatory malignant fibrous his-tiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203(3):822–830

    Article  PubMed  CAS  Google Scholar 

  34. Shepherd V, Davidson EJ, Davies-Humphreys J (2005) Extramammary Paget's disease. BJOG 112(3):273–279

    Article  PubMed  Google Scholar 

  35. Coldiron BM, Goldsmith BA, Robinson JK (1991) Surgical treatment of extramammary Paget's disease. A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 67(4):933–938

    Article  PubMed  CAS  Google Scholar 

  36. Zollo JD, Zeitouni NC (2000) The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 142(1):59–65

    Article  PubMed  CAS  Google Scholar 

  37. O'Connor WJ et al (2003) Comparison of mohs micro-graphic surgery and wide excision for extramammary Paget's disease. Dermatol Surg 29(7):723–727

    Article  PubMed  Google Scholar 

  38. Cohen PR et al (2006) Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 99(4):396–402

    Article  PubMed  Google Scholar 

  39. Gregori CA, Smith CI, Breen JL (1978) Extramammary Paget's disease. Clin Obstet Gynecol 21(4):1107–1115

    Article  PubMed  CAS  Google Scholar 

  40. Chanda JJ (1985) Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 13(6):1009–1014

    Article  PubMed  CAS  Google Scholar 

  41. Kanitakis J (2007) Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 21(5):581–590

    PubMed  CAS  Google Scholar 

  42. Marchesa P et al (1997) Long-term outcome of patients with perianal Paget's disease. Ann Surg Oncol 4(6):475–480

    Article  PubMed  CAS  Google Scholar 

  43. Lundquist K, Kohler S, Rouse RV (1999) Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells. Am J Surg Pathol 23(2):212–219

    Article  PubMed  CAS  Google Scholar 

  44. Smith KJ et al (1997) Cytokeratin 7 staining in mammary and extramammary Paget's disease. Mod Pathol 10(11):1069–1074

    PubMed  CAS  Google Scholar 

  45. Hendi A, Brodland DG, Zitelli JA (2004) Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 51(5):767–773

    Article  PubMed  Google Scholar 

  46. Thomas CJ, Wood GC, Marks VJ (2007) Mohs micro-graphic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg 33(3):333–339

    Article  PubMed  CAS  Google Scholar 

  47. Louis-Sylvestre C, Haddad B, Paniel BJ (2001) Paget's disease of the vulva: results of different conservative treatments. Eur J Obstet Gynecol Reprod Biol 99(2):253–255

    Article  PubMed  CAS  Google Scholar 

  48. Watanabe Y et al (2002) Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease. Int J Gynecol Cancer 12(3):304–307

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vanderbilt University, Nashville, Tennessee, 3900, USA

    Thomas Stasko

  2. The Vanderbilt Clinic, Nashville, TN, 37232-5227, USA

    Thomas Stasko

Authors
  1. Thomas Stasko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Grummer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Stasko .

Editor information

Editors and Affiliations

  1. Skin Cancer Center Charité, Department of Dermatology, Charité University Medicine Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Eggert Stockfleth

  2. Department of Dermatology, 6620 Main Street, Suite 1425, Houston, TX, 77030, USA

    Theodore Rosen (Chief of VA Dermatology Clinic Professor) (Chief of VA Dermatology Clinic Professor)

  3. Ground Floor, 225 Macquarie Street, Sydney, NSW, 2000, Australia

    Stephen Shumack

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stasko, T., Grummer, S. (2010). Other Skin Cancers. In: Stockfleth, E., Rosen, T., Shumack, S. (eds) Managing Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79347-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79347-2_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79346-5

  • Online ISBN: 978-3-540-79347-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation